Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Song, Kwon-Ho | - |
dc.contributor.author | Kim, Jae-Hoon | - |
dc.contributor.author | Lee, Young-Ho | - |
dc.contributor.author | Bae, Hyun Cheol | - |
dc.contributor.author | Lee, Hyo-Jung | - |
dc.contributor.author | Woo, Seon Rang | - |
dc.contributor.author | Oh, Se Jin | - |
dc.contributor.author | Lee, Kyung-Mi | - |
dc.contributor.author | Yee, Cassian | - |
dc.contributor.author | Kim, Bo Wook | - |
dc.contributor.author | Cho, Hanbyoul | - |
dc.contributor.author | Chung, Eun Joo | - |
dc.contributor.author | Chung, Joon-Yong | - |
dc.contributor.author | Hewitt, Stephen M. | - |
dc.contributor.author | Chung, Tae-Wook | - |
dc.contributor.author | Ha, Ki-Tae | - |
dc.contributor.author | Bae, Young-Ki | - |
dc.contributor.author | Mao, Chih-Ping | - |
dc.contributor.author | Yang, Andrew | - |
dc.contributor.author | Wu, T. C. | - |
dc.contributor.author | Kim, Tae Woo | - |
dc.date.accessioned | 2021-09-02T07:34:00Z | - |
dc.date.available | 2021-09-02T07:34:00Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-08-31 | - |
dc.identifier.issn | 0021-9738 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/73709 | - |
dc.description.abstract | The host immune system plays a pivotal role in the emergence of tumor cells that are refractory to multiple clinical interventions including immunotherapy, chemotherapy, and radiotherapy. Here, we examined the molecular mechanisms by which the immune system triggers cross-resistance to these interventions. By examining the biological changes in murine and tumor cells subjected to sequential rounds of in vitro or in vivo immune selection via cognate cytotoxic T lymphocytes, we found that multimodality resistance arises through a core metabolic reprogramming pathway instigated by epigenetic loss of the ATP synthase subunit ATP5H, which leads to ROS accumulation and HIF-1 alpha stabilization under normoxia. Furthermore, this pathway confers to tumor cells a stem-like and invasive phenotype. In vivo delivery of antioxidants reverses these phenotypic changes and resensitizes tumor cells to therapy. ATP5H loss in the tumor is strongly linked to failure of therapy, disease progression, and poor survival in patients with cancer. Collectively, our results reveal a mechanism underlying immune-driven multimodality resistance to cancer therapy and demonstrate that rational targeting of mitochondrial metabolic reprogramming in tumor cells may overcome this resistance. We believe these results hold important implications for the clinical management of cancer. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | AMER SOC CLINICAL INVESTIGATION INC | - |
dc.subject | DRUG-RESISTANCE | - |
dc.subject | LUNG-CANCER | - |
dc.subject | HIF-ALPHA | - |
dc.subject | OXYGEN | - |
dc.subject | MECHANISM | - |
dc.subject | MELANOMA | - |
dc.subject | ROS | - |
dc.subject | 5-FLUOROURACIL | - |
dc.subject | INHIBITION | - |
dc.subject | PHENOTYPE | - |
dc.title | Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Song, Kwon-Ho | - |
dc.contributor.affiliatedAuthor | Woo, Seon Rang | - |
dc.contributor.affiliatedAuthor | Lee, Kyung-Mi | - |
dc.contributor.affiliatedAuthor | Kim, Tae Woo | - |
dc.identifier.doi | 10.1172/JCI96804 | - |
dc.identifier.scopusid | 2-s2.0-85052579979 | - |
dc.identifier.wosid | 000443283400043 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL INVESTIGATION, v.128, no.9, pp.4098 - 4114 | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL INVESTIGATION | - |
dc.citation.title | JOURNAL OF CLINICAL INVESTIGATION | - |
dc.citation.volume | 128 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 4098 | - |
dc.citation.endPage | 4114 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | DRUG-RESISTANCE | - |
dc.subject.keywordPlus | LUNG-CANCER | - |
dc.subject.keywordPlus | HIF-ALPHA | - |
dc.subject.keywordPlus | OXYGEN | - |
dc.subject.keywordPlus | MECHANISM | - |
dc.subject.keywordPlus | MELANOMA | - |
dc.subject.keywordPlus | ROS | - |
dc.subject.keywordPlus | 5-FLUOROURACIL | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | PHENOTYPE | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.